Results 161 to 170 of about 10,664 (186)
Some of the next articles are maybe not open access.

Canakinumab in gout

Expert Opinion on Biological Therapy, 2012
Gout is a painful inflammatory arthritis with a prevalence of approximately 4% in the United States, affecting an estimated 8.3 million adults. The past 20 years have shown significant increases in the number of patients with gout and its incidence may still be increasing.
Naomi Schlesinger
exaly   +3 more sources

Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort

Rheumatology, 2021
Claudia Bracaglia   +2 more
exaly  

Home - About - Disclaimer - Privacy